Neuropeptides
Volume 44, Issue 2 , Pages 93-97 , April 2010

Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-β 1-40 peptide in mice

  • Fabio Agostini Amaral

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • ,
  • Mayra Tolentino Resk Lemos

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • ,
  • Karis Ester Dong

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • ,
  • Maria Fernanda Queiroz Prado Bittencourt

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • ,
  • Ariadiny Lima Caetano

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • ,
  • João Bosco Pesquero

      Affiliations

    • Department of Biophysics, Universidade Federal de São Paulo, Rua Botucatu, 862, 7° andar, São Paulo, SP, CEP 04023-900l, Brazil
    • ,
  • Tania Araujo Viel

      Affiliations

    • School of Arts, Sciences and Humanities, Universidade de São Paulo, Rua Arlindo Bettio, 1000, São Paulo, SP, CEP 03828-000, Brazil
    • ,
  • Hudson Sousa Buck

      Affiliations

    • Department of Physiological Sciences, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Dr. Cesario Motta Junior, 61, São Paulo, SP, CEP 01221-020, Brazil
    • Corresponding Author InformationCorresponding author. Tel./fax: +55 11 3331 2008.

References 

  1. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension. Circ. Res. 2001;88:275–281
  2. Duka I, Duka A, Kintsurashvili E, Johns C, Gavras I, Gavras H. Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin. Hypertension. 2003;42:1021–1025
  3. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. third ed.. San Diego: Academic Press; 2007;
  4. Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F, et al. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 1998;18(20):8311–8321
  5. Huang HM, Lin TA, Sun GY, Gibson GE. Increased inositol 1,4,5-trisphosphate accumulation correlates with an up-regulation of bradykinin receptors in Alzheimer’s disease. J. Neurochem. 1995;64(2):761–766
  6. Iores-Marçal LM, Viel TA, Buck HS, Nunes VA, Gozzo AJ, Cruz-Silva I, et al. Brain prolyl oligopeptidase inactivates bradykinin in a model of Alzheimer’s disease. Peptides. 2006;27(12):3363–3369
  7. Jong YJ, Dalemar LR, Seehra K, Baenziger NL. Bradykinin receptor modulation in cellular models of aging and Alzheimer’s disease. Int. Immunopharmacol. 2002;2(13–14):1833–1840
  8. Jong YJ, Ford SR, Seehra K, Malave VB, Baenziger NL. Alzheimer’s disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation. FASEB J. 2003;17(15):2319–2321
  9. Joseph K, Shibayama Y, Nakazawa Y, Peerschke EI, Ghebrehiwet B, Kaplan AP. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer’s disease. Immunopharmacology. 1999;43:203–210
  10. Leeb-Lundberg LMF, Marceau F, Ller-Esterl WM, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005;57:27–77
  11. Lemos, M.T.R., Dong, K.E., Amaral, F.A., Bittencourt, M.F.Q.P., Caetano, A.L., Pesquero, J.B., Viel, T.A., Buck, H.S., Role of kinin B1 and B2 receptors on memory consolidation during aging process of mice. Neuropeptides, submitted for publication.
  12. Maestri R, Milia AF, Salis MB, Graiani G, Lagrasta C, Monica M, et al. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension. 2003;41:1151–1155
  13. Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol. Rev. 1998;50:357–386
  14. McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, et al. Expression cloning of a rat B2 bradykinin receptor. Proc. Natl. Acad. Sci. USA. 1991;88(17):7724–7728
  15. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:741–749
  16. Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, et al. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 1994;269(34):21583–21586
  17. Nitsch RM, Kim C, Growdon JH. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer’s disease. Neurochem. Res. 1998;23(5):807–814
  18. Prat A, Weinrib L, Becher B, Poirier J, Duquette P, Couture R, et al. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology. 1999;53:2087–2092
  19. Prat A, Biernacki K, Pouly S, Nalbantoglu J, Couture R, Antel JP. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropat. Exp. Neurol. 2000;59:896–906
  20. Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, et al. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer’s disease. Neuroscience. 2008;151(3):631–643
  21. Racchi M, Ianna P, Binetti G, Trabucchi M, Govoni S. Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer’s disease. Biochem. J. 1998;330(Pt 3):1271–1275
  22. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980;32:1–46
  23. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer’s disease: amyloid-b oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 2009;87:181–194
  24. Vanzeler ML, Felicio LF, Nasello AG. Effects of chronic domperidone treatment on rat conditioned avoidance behavior. Braz. J. Med. Biol. Res. 1990;23(9):865–868
  25. Viel TA, Lima Caetano A, Nasello AG, Lancelotti CL, Nunes VA, Araujo MS, et al. Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats. Neurobiol. Aging. 2008;29(12):1805–1814
  26. Zhao WQ, Ravindranath L, Mohamed AS, Zohar O, Chen GH, Lyketsos CG, et al. MAPkinase signaling cascade dysfunction specific to Alzheimer’s disease in fibroblast. Neurobiol. Dis. 2002;11(1):166–183

PII: S0143-4179(09)00115-2

doi: 10.1016/j.npep.2009.10.006

Neuropeptides
Volume 44, Issue 2 , Pages 93-97 , April 2010

Article Tools

* Image Usage & Resolution